Medclair AB (NGM:MCLR)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.945
+0.015 (0.78%)
At close: Jul 3, 2025
66.24%
Market Cap 160.45M
Revenue (ttm) 40.00M
Net Income (ttm) 3.46M
Shares Out 82.49M
EPS (ttm) 0.04
PE Ratio 44.42
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 79,208
Average Volume 76,491
Open n/a
Previous Close 1.930
Day's Range n/a
52-Week Range 1.155 - 2.240
Beta 0.67
RSI 56.61
Earnings Date Aug 8, 2025

About Medclair AB

Medclair AB, a research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O). It offers mobile destruction unit, a solution that can be moved anywhere, where N2O is needed for pain relief; central destruction unit, a system designed for larger N2O destruction volumes; exhalation device that addresses the problem with residual levels of N2O in the patient’s exhalation; collection units for non-frequent use of N2O, and less frequent use or fitting in emergency services vehicles; and Nitrous O... [Read more]

Industry Crude Petroleum and Natural Gas
Founded 2008
Employees 14
Stock Exchange Nordic Growth Market
Ticker Symbol MCLR
Full Company Profile

Financial Performance

In 2024, Medclair AB's revenue was 35.95 million, a decrease of -15.25% compared to the previous year's 42.42 million. Losses were -664,000, -76.16% less than in 2023.

Financial Statements

News

There is no news available yet.